Cargando…

Experience with alendronate treatment for four years among Japanese men with osteoporosis or osteopenia and clinical risk factors for fractures

PURPOSE: A retrospective study based on a conventional medical practice was performed to evaluate the outcome of alendronate treatment for four years in Japanese men with osteoporosis or osteopenia and clinical risk factors for fractures. METHODS: Twenty-nine Japanese men with osteoporosis or osteop...

Descripción completa

Detalles Bibliográficos
Autores principales:	Iwamoto, Jun, Sato, Yoshihiro, Uzawa, Mitsuyoshi, Takeda, Tsuyoshi, Matsumoto, Hideo
Formato:	Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2010
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3012448/ https://www.ncbi.nlm.nih.gov/pubmed/21206758 http://dx.doi.org/10.2147/TCRM.S15812

Ejemplares similares

Comparison of the Effects of Alendronate and Alfacalcidol on Hip Bone Mineral Density and Bone Turnover in Japanese Men Having Osteoporosis or Osteopenia with Clinical Risk Factors for Fractures
por: Iwamoto, Jun, et al.
Publicado: (2009)

Seven years’ experience with alendronate in postmenopausal Japanese women with osteoporosis
por: Iwamoto, Jun, et al.
Publicado: (2010)

Five-year alendronate treatment outcome in older postmenopausal Japanese women with osteoporosis or osteopenia and clinical risk factors for fractures
por: Iwamoto, Jun, et al.
Publicado: (2009)

Three-year experience with combined treatment with alendronate and alfacalcidol in Japanese patients with severe bone loss and osteoporotic fracture
por: Iwamoto, Jun, et al.
Publicado: (2011)

Comparison of Effects of Alendronate and Raloxifene on Lumbar Bone Mineral Density, Bone Turnover, and Lipid Metabolism in Elderly Women with Osteoporosis
por: Iwamoto, Jun, et al.
Publicado: (2008)

Effects of short-term combined treatment with alendronate and elcatonin on bone mineral density and bone turnover in postmenopausal women with osteoporosis
por: Iwamoto, Jun, et al.
Publicado: (2009)

Comparison of Effect of Treatment with Etidronate and Alendronate on Lumbar Bone Mineral Density in Elderly Women with Osteoporosis
por: Iwamoto, Jun, et al.
Publicado: (2005)

A Radiographic Study on the Associations of Age and Prevalence of Vertebral Fractures with Abdominal Aortic Calcification in Japanese Postmenopausal Women and Men
por: Iwamoto, Jun, et al.
Publicado: (2009)

Hip fracture protection by alendronate treatment in postmenopausal women with osteoporosis: a review of the literature
por: Iwamoto, Jun, et al.
Publicado: (2008)

Experience with Alendronate Treatment for Four Years among Japanese Men with Osteoporosis or Osteopenia and Clinical Risk Factors for Fractures [Retraction]
Publicado: (2022)

Experience with alendronate treatment for four years among Japanese men with osteoporosis or osteopenia and clinical risk factors for fractures [Expression of concern]
Publicado: (2018)

Five-year follow-up of a woman with pregnancy and lactation-associated osteoporosis and vertebral fractures
por: Iwamoto, Jun, et al.
Publicado: (2012)

Seven years’ experience with etidronate in a woman with anorexia nervosa and vertebral fractures
por: Iwamoto, Jun, et al.
Publicado: (2011)

Effects of Vitamin K(2) on the Development of Osteopenia in Rats as the Models of Osteoporosis
por: Iwamoto, Jun, et al.
Publicado: (2006)

Influence of treatment with alendronate on the speed of sound, an ultrasound parameter, of the calcaneus in postmenopausal Japanese women with osteoporosis: a clinical practice-based observational study
por: Iwamoto, Jun, et al.
Publicado: (2012)

Eleven years of experience with bisphosphonate plus alfacalcidol treatment in a man with osteogenesis imperfecta type I
por: Iwamoto, Jun, et al.
Publicado: (2013)

Serum Leptin Concentration Positively Correlates with Body Weight and Total Fat Mass in Postmenopausal Japanese Women with Osteoarthritis of the Knee
por: Iwamoto, Jun, et al.
Publicado: (2011)

Prevention and Treatment of Corticosteroid-Induced Osteoporosis
por: Iwamoto, Jun, et al.
Publicado: (2005)

10-Year Fracture Risk in Postmenopausal Women with Osteopenia and Osteoporosis in South Korea
por: Baek, Yeon-Hee, et al.
Publicado: (2021)

Retraction: Preventive effects of risedronate and calcitriol on cancellous osteopenia in ratstreated with high-dose glucocorticoid
por: IWAMOTO, Jun, et al.
Publicado: (2019)

Systematic review of raloxifene in postmenopausal Japanese women with osteoporosis or low bone mass (osteopenia)
por: Fujiwara, Saeko, et al.
Publicado: (2014)

Retraction: Comparative effects of alendronate and alfacalcidol on cancellous and cortical bone mass and bone mechanical properties in ovariectomized rats
por: IWAMOTO, Jun, et al.
Publicado: (2018)

Treatment with once‐weekly alendronate oral jelly compared with once‐weekly alendronate oral tablet for Japanese patients with primary osteoporosis: An open‐label, prospective, observational study
por: Okimoto, Nobukazu, et al.
Publicado: (2018)

Alendronate Sodium in the Management of Osteoporosis
por: Prinsloo, P J J, et al.
Publicado: (2006)

Osteopenia and the physical function in Japanese patients with schizophrenia
por: Uchida, Satoru, et al.
Publicado: (2017)

Effects of pentoxifylline and alendronate on fracture healing in ovariectomy-induced osteoporosis in rats
por: Vashghani Farahani, Mohammad-Mahdi, et al.
Publicado: (2019)

Effects of Risedronate on Osteoarthritis of the Knee
por: Iwamoto, Jun, et al.
Publicado: (2010)

Return to play after conservative treatment in athletes with symptomatic lumbar disc herniation: a practice-based observational study
por: Iwamoto, Jun, et al.
Publicado: (2011)

Retraction: Paper “Comparison of the Effects of Alendronate and Alfacalcidol on Hip Bone Mineral Density and Bone Turnover in Japanese Men Having Osteoporosis or Osteopenia with Clinical Risk Factors for Fractures” by Iwamoto J, et al. [Yonsei Med J 2009 Aug;50(4):474-481]
Publicado: (2023)

Osteoporosis, osteopenia, and atherosclerotic vascular disease
por: Aronow, Wilbert S.
Publicado: (2011)

Osteopenia and osteoporosis associated with hyperprolactinemic antipsychotics
por: Montejo, A. L., et al.
Publicado: (2023)

Prevalence of osteoporosis and osteopenia in men and premenopausal women with celiac disease: a systematic review
por: Ganji, Reza, et al.
Publicado: (2019)

Effect of Abaloparatide vs Alendronate on Fracture Risk Reduction in Postmenopausal Women With Osteoporosis
por: Leder, Benjamin Z, et al.
Publicado: (2019)

Sequential therapy with once-weekly teriparatide injection followed by alendronate versus monotherapy with alendronate alone in patients at high risk of osteoporotic fracture: final results of the Japanese Osteoporosis Intervention Trial-05
por: Mori, Satoshi, et al.
Publicado: (2022)

Disparities in the Prevalence of Osteoporosis and Osteopenia in Men and Women Living in Sub-Saharan Africa, the UK, and the USA
por: Ward, Kate A., et al.
Publicado: (2023)

The association between iliocostal distance and the number of vertebral and non-vertebral fractures in women and men registered in the Canadian Database For Osteoporosis and Osteopenia (CANDOO)
por: Olszynski, WP, et al.
Publicado: (2002)

Alendronate improves QOL of postmenopausal women with osteoporosis
por: Kawate, Hisaya, et al.
Publicado: (2010)

Do Estrogen and Alendronate Improve Metaphyseal Fracture Healing When Applied as Osteoporosis Prophylaxis?
por: Kolios, Leila, et al.
Publicado: (2009)

ERRATUM for “Effect of Abaloparatide vs Alendronate on Fracture Risk Reduction in Postmenopausal Women With Osteoporosis”
Publicado: (2020)

Osteopenia and osteoporosis in people living with HIV: multiprofessional approach
por: Lima, Ana Lucia Lei Munhoz, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_6qq2euljf39lmnnfkr5r497hn0